The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Melanoma Statistics

Forums General Melanoma Community Melanoma Statistics

  • Post
    Mark
    Participant
      Yesterday I was diagnosed with invasive melanoma and my tumor was 5.5mm, I haven’t had tests/scans yet to fully determine staging. While waiting for the results of the biopsy I researched survival rates and those numbers are distressing. However, I have also read that the majority of the statistics you see on the internet are based off of historical data that has not had time to fully factor in the effectiveness of immunotherapy on survival rate statistics. For those of you that have talked with your doctors about immunotherapy and survival rates recently, is there reason to be more optimistic about immunotherapy success and increased survival rates?

      Thanks.

    Viewing 3 reply threads
    • Replies
        Bubbles
        Participant
          Sorry you have a need to be here, Mark. But first and foremost – ain’t nothin for sure in melanoma. Yes, it seems as though you have a large primary lesion. However, you don’t know your stage until you know. Sentinel node biopsy and scans will tell the tale. Melanoma is nothing if unpredictable!

          AIM at melanoma has a very good break down of melanoma staging that you may find helpful. Here is info on Stage III – Stage III melanoma Here is a link to info on Stage IV – Stage IV melanoma

          However, here are some posts that address some of what you are asking about:

          Here is something I wrote for folks (mostly Stage III) looking at adjuvant care: State of the science for adjuvant care

          Finally, this primer, updated this year, on melanoma treatment generally may be helpful: Current Melanoma Treatments

          When looking at melanoma data (or any data really) it is important to be sure you are comparing apples to apples. Outcome data for advanced melanoma patients is not at all the same as it is for Stage I patients or even those who are Stage III. But, the bottom line is this – there is hope and knowledge is power.

          Feel free to use the search bubble on my blog if you like for more info. Currently, I am LIVING post Stage IIIB melanoma diagnosis in 2003 and Stage IV melanoma in 2010 (with brain and lung mets) and 2 1/2 year phase 1 nivolumab trial with last dose in June 2013 – NED for melanoma since 2010!

          I hope these links help you. Will keep fingers and toes crossed that you are determined to have the lowest disease burden possible. Take good care and ask more questions as you have the need. There are many smart, caring melanoma peeps on this forum. I wish you my best. Celeste

          Mark
          Participant
            Thanks for the quick response. With the size of my tumor I am expecting a Stage IV diagnosis, but am praying for better news.  My follow up questions are a lot of what I’m reading about immunotherapy has to do with clinic trials.  Is most of immunotherapy still being conducted via clinic trials, or have we advanced enough that immunotherapy can be the standard protocol for melanoma late stage treatment without the requirement of being in a clinical trial? What has been shown lately to be the best practice for choosing which doctor or cancer center you think is best? (I know this will depend on how far away from the hospital or cancer center you are using).

            Bubbles
            Participant
              In the “primer” I linked you to – all of the treatments included are FDA approved, many are now the “standard of care” and none require trial participation at this time. Immunotherapy in the form of ipi/nivo, Opdivo or Keytruda alone are first line care for melanoma patients in the average oncology office. Targeted therapy in the form of a BRAF inhibitor combined with a MEK inhibitor are also standard of care for melanoma BRAF positive patients without the need of a trial. I think things will be much more clear when you review the links. Hope that helps. c
              Bubbles
              Participant
                Also, meant to include this in first post – there is this for ADVANCED melanoma patients: 5 year survival reports in melanoma

                Understand that this does NOT mean that melanoma patients survive only 5 years!!!!! c

            Viewing 3 reply threads
            • You must be logged in to reply to this topic.
            About the MRF Patient Forum

            The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

            The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

            Popular Topics